Vitamin D deficiency: consequence or cause of CKD?
作者信息
de Boer Ian H, Thadhani Ravi
机构信息
Division of Nephrology, and Kidney Research Institute, Departments of Medicine and Epidemiology, University of Washington, Seattle, Washington, †Division of Nephrology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts.
出版信息
Clin J Am Soc Nephrol. 2013 Nov;8(11):1844-6. doi: 10.2215/CJN.09480913. Epub 2013 Oct 17.
Abstract
摘要
相似文献
1
Vitamin D deficiency: consequence or cause of CKD?
Clin J Am Soc Nephrol. 2013 Nov;8(11):1844-6. doi: 10.2215/CJN.09480913. Epub 2013 Oct 17.
2
25 (OH) vitamin D levels and renal disease progression in patients with type 2 diabetic nephropathy and blockade of the renin-angiotensin system.
Clin J Am Soc Nephrol. 2013 Nov;8(11):1870-6. doi: 10.2215/CJN.00910113. Epub 2013 Oct 17.
3
Renin angiotensin system (RAS) blockade and diabetic microvascular complications in the eye and kidney.
Prim Care Diabetes. 2008 Dec;2(4):201-2. doi: 10.1016/j.pcd.2008.06.002. Epub 2008 Aug 28.
4
Renoprotection by blocking the RAAS in diabetic nephropathy--fact or fiction?
Nephrol Dial Transplant. 2006 Sep;21(9):2354-7; discussion 2357-8. doi: 10.1093/ndt/gfl454.
5
Probucol in Albuminuric Type 2 Diabetes Mellitus Patients on Renin-Angiotensin System Blockade: A 16-Week, Randomized, Double-Blind, Placebo-Controlled Trial.
Arterioscler Thromb Vasc Biol. 2016 Oct;36(10):2108-14. doi: 10.1161/ATVBAHA.116.308034. Epub 2016 Aug 4.
6
Can two be better than one? Dual RAS blockade in patients with type 2 diabetes and overt nephropathy in the age of ONTARGET and ALTITUDE.
Hypertens Res. 2014 Jan;37(1):4-6. doi: 10.1038/hr.2013.91. Epub 2013 Sep 12.
7
Renal effects of dual renin-angiotensin-aldosterone system blockade in patients with diabetic nephropathy.
Int Urol Nephrol. 2009;41(1):119-26. doi: 10.1007/s11255-008-9490-0. Epub 2008 Oct 29.
8
Dual renin-angiotensin-aldosterone system inhibition: boon or bust?
Int J Clin Pract. 2010 Sep;64(10):1337-40. doi: 10.1111/j.1742-1241.2010.02367.x.
9
Treating diabetic nephropathy: unfinished success is not failure.
Clin J Am Soc Nephrol. 2007 May;2(3):407-9. doi: 10.2215/CJN.01170307. Epub 2007 Apr 11.
10
[RAS blockade in diabetic nephropathy. "Early intervention can dramatically decrease loss of function].
MMW Fortschr Med. 2004 Sep 16;146(38):12.
引用本文的文献
1
Chronic Kidney Disease Diets for Kidney Failure Prevention: Insights from the IL-11 Paradigm.
Nutrients. 2024 Apr 29;16(9):1342. doi: 10.3390/nu16091342.
2
The Role of Vitamin D in Diabetic Nephropathy: A Translational Approach.
Int J Mol Sci. 2022 Jan 12;23(2):807. doi: 10.3390/ijms23020807.
3
Vitamin D deficiency--prognostic marker or mortality risk factor in end stage renal disease patients with diabetes mellitus treated with hemodialysis--a prospective multicenter study.
PLoS One. 2015 May 12;10(5):e0126586. doi: 10.1371/journal.pone.0126586. eCollection 2015.
本文引用的文献
1
25 (OH) vitamin D levels and renal disease progression in patients with type 2 diabetic nephropathy and blockade of the renin-angiotensin system.
Clin J Am Soc Nephrol. 2013 Nov;8(11):1870-6. doi: 10.2215/CJN.00910113. Epub 2013 Oct 17.
2
Active vitamin D treatment for reduction of residual proteinuria: a systematic review.
J Am Soc Nephrol. 2013 Nov;24(11):1863-71. doi: 10.1681/ASN.2013030203. Epub 2013 Aug 8.
3
Racial differences in the association of serum 25-hydroxyvitamin D concentration with coronary heart disease events.
JAMA. 2013 Jul 10;310(2):179-88. doi: 10.1001/jama.2013.7228.
4
Genetic variants and associations of 25-hydroxyvitamin D concentrations with major clinical outcomes.
JAMA. 2012 Nov 14;308(18):1898-905. doi: 10.1001/jama.2012.17304.
5
Vitamin D receptor signaling in podocytes protects against diabetic nephropathy.
J Am Soc Nephrol. 2012 Dec;23(12):1977-86. doi: 10.1681/ASN.2012040383. Epub 2012 Nov 2.
6
Circulating vitamin D metabolites and kidney disease in type 1 diabetes.
J Clin Endocrinol Metab. 2012 Dec;97(12):4780-8. doi: 10.1210/jc.2012-2852. Epub 2012 Sep 18.
7
Paricalcitol does not improve glucose metabolism in patients with stage 3-4 chronic kidney disease.
Kidney Int. 2013 Feb;83(2):323-30. doi: 10.1038/ki.2012.311. Epub 2012 Aug 22.
8
Associations of plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D concentrations with death and progression to maintenance dialysis in patients with advanced kidney disease.
Am J Kidney Dis. 2012 Oct;60(4):567-75. doi: 10.1053/j.ajkd.2012.04.014. Epub 2012 May 22.
9
Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial.
JAMA. 2012 Feb 15;307(7):674-84. doi: 10.1001/jama.2012.120.
10
Serum 25-hydroxyvitamin D and change in estimated glomerular filtration rate.
Clin J Am Soc Nephrol. 2011 Sep;6(9):2141-9. doi: 10.2215/CJN.02640311. Epub 2011 Aug 11.
Zotero 插件